{
  "trial_id": "NCT01051726",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "women in labour and expecting a normal delivery",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "aged > 16 who are able to make informed consent",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "singleton pregnancy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "spontaneous or induced labour onset",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "prior to elective or emergency caesarean section",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "preterm labour",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "pool births",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "scheduled caesarean section",
      "label": "does_not_trigger",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has history of acne and mild hirsutism, elevated testosterone levels, gradual enlargement of hands and feet, irregular menstrual cycle, nipple discharge, snoring, headache, facial features of acromegaly, prognathism, soft tissue thickening, diaphoresis. Laboratory evaluation reveals IGF-1 of 968 ng/mL and random GH of 19.7 ng/mL.",
  "_meta": {
    "topic_id": "20",
    "trial_id": "NCT01051726",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}